Editor's Note

Welcome to the third issue of Xtalks Clinical Edge — where innovation meets expertise!

This issue focuses on the critical importance of patient diversity in clinical research, showcasing the impactful contributions of professionals dedicated to this essential aspect of the field.

We've brought together insights from key opinion leaders driving diversity efforts in clinical trials, featuring contributions from the Clinical Trials Transformation Initiative (CTTI), the Foundation for the National Institutes of Health (FNIH), Pfizer and others. You’ll also learn from a wide range of pharmaceutical and biotech companies, and leading clinical research organizations (CROs) that are leading the progress in this area.

Every quarter, Xtalks Clinical Edge highlights conversations with leading innovators and influential figures within the clinical trials community. Our aim is to provide you with valuable perspectives and direct insights into the evolving landscape of clinical research.

As you explore this issue, we hope you find inspiration and a deeper understanding of the leaders who are at the forefront of advancing clinical trials.

Be sure to mark your calendar for our next issue, coming in March 2025.